Navigation Links
Increased Dosage of Needle-Free Erectile Dysfunction Medication TriMix-gel Now Available through KRS Global Biotechnology

BOCA RATON, Fla., May 7, 2013 /PRNewswire/ -- TriMix Laboratories, LLC and KRS Global Biotechnology, INC today announced the availability of TriMix-gel® in a 2000 microgram dose.  The joint developmental effort is the result of physicians and patients asking if it was possible for TriMix-gel to come in an increased dosage.  After development and testing, the new dosage is available immediately from KRS Global Biotechnology on the prescription of a licensed physician. 

TriMix-gel was introduced at the American Urological Association's World Conference.  Since then, thousands of American physicians have prescribed TriMix-gel for patients who cannot tolerate self-injection with a needle or who failed on PDE5 Inhibitors such as Viagra, Levitra or Cialis (J. Urol. 179 (4): 431, 2008).

Each individual dose of TriMix-gel is shipped to the patient in an ED-GEL™ applicator.  This novel, patent pending applicator, stores, mixes and applies the medicine without the patient having to self-inject himself with a needle.  Three short videos are available at  These videos are important in helping doctors and patients understand how to order TriMix-gel and how to apply the medicine.

TriMix Laboratories LLC develops innovative products toward the clinical advancement of urology.  For more information, visit .  KRS Global Biotechnology is a recognized leader in pharmaceutical compounding, helping Physicians and Veterinarians with medicine precisely customized for each individual patient.  KRS maintains state licenses and dispenses compounded medications in almost all states. For more information, visit .

The information contained herein is general in nature and is intended for use only as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems. TriMix-gel has not been evaluated by the Food and Drug Administration (FDA) and is not made under GMP requirements. It is compounded in a licensed compounding pharmacy. The compound is for the use of an individual patient who has been prescribed TriMix-gel by a licensed physician.  The information contained herein is not intended for making an evaluation as to suitability, risks or benefits. Before taking any action, consult your Physician.

Contact: T.J. Harkins
TriMix Laboratories

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE TriMix Laboratories
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
2. Covance Expands Singapore Central Laboratory by 50 Percent to Meet Clients Increased Asia Pacific Focus
3. Hemodialysis Patient Share for Sanofis Ferrlecit Increased Significantly in the First Quarter of 2013 Compared to the Previous Quarter
4. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
5. Niacin Causes Serious Unexpected Side-effects, but no Worthwhile Benefits, for Patients who are at Increased Risk of Heart Attacks and Strokes
6. Sigma-Aldrich Reports Record Full Year 2012 Results. Reports Q4 2012 Diluted EPS Of $0.96. Q4 2012 Sales Increased 7%. Full Year 2012 Adjusted Diluted EPS Was $3.85. Expects Full Year 2013 Adjusted Diluted EPS To Increase To $4.10 - $4.20.
7. Amgens Full Year 2012 Revenues Increased 11 Percent To $17.3 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $6.51
8. Murray Dental Laboratory Deploys Jensen Dental CAD/CAM Solution for Increased Productivity, Higher Sales and More Consistent Restorations
9. Medbox, Inc. Announced Increased Funding for Corporate Giving Program in 2013
10. DePuy Settlement Funding And Transvaginal Mesh Capital Increased At Legal-Bay
11. Artificial disc brings increased mobility and rapid recovery to patients suffering chronic neck pain in the Midwest
Post Your Comments:
(Date:12/1/2015)... , December 1, 2015 ... new market research report "Nucleic Acid Labeling Market by ... Nick Translation, Random Primer, In Vitro Transcription, Reverse Transcription, ... published by MarketsandMarkets, The global market is expected to ... Million in 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , December 1, 2015 Russia ... clinical trials. 70% of new drugs registered in Europe ... Russia . --> Russia has always been ... of new drugs registered in Europe in 2015 ... --> Russia has always been a country ...
(Date:12/1/2015)... 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage ... announced today that the company will present at the LD ... at the Luxe Sunset Boulevard Hotel in Los ... Relmada Therapeutics, will present on Thursday, December 3, at 9:00 ... . Please register at least 10 minutes prior to the ...
Breaking Medicine Technology:
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... in the 1980s we have seen vast improvements in scientific research and discoveries, ... significant strides, providing increased hope and relief to those affected by HIV/AIDS. Mediaplanet’s ...
(Date:12/1/2015)... New York, NY (PRWEB) , ... December 01, ... ... cause of non-traumatic limb amputations in the United States. Podiatrists are well aware ... (failure to adopt therapeutic behaviors) are often catastrophic contributors to diseases of the ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), ... at the Radiological Society of North America (RSNA) 2015 annual meeting through December ...
(Date:12/1/2015)... ... December 01, 2015 , ... Lutronic, a leading innovator of aesthetic and ... to the devices for sale in the United States. Clarity is a Superior ... nm Nd:YAG lasers, into a single platform that is easy to own and operate. ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... and SACC-USA through membership and leadership since 2008. Gary Bruce, President of PartnerTech ... . Gary has spent a significant amount of time in Sweden since joining ...
Breaking Medicine News(10 mins):